{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:01:43Z","timestamp":1787014903450,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":5242,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1111\/j.1538-7836.2008.03015.x","type":"journal-article","created":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T07:40:25Z","timestamp":1210750825000},"page":"1336-1343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies"],"prefix":"10.1016","volume":"6","author":[{"given":"Q.M.","family":"ANSTEE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"GOLDIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"WRIGHT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"MARTINELLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"COX","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"THURSZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2008.03015.x_bb0010","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis \u2010 from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2007.02772.x","article-title":"Hypercoagulation and thrombophilia in liver disease","volume":"6","author":"Northup","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0020","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.1840030614","article-title":"The effect of mouse hepatitis virus infection on the microcirculation of the liver","volume":"3","author":"Levy","year":"1983","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0026-2862(88)90014-3","article-title":"Microcirculatory changes in livers of mice infected with murine hepatitis virus. Evidence from microcorrosion casts and measurements of red cell velocity","volume":"36","author":"MacPhee","year":"1988","journal-title":"Microvasc Res"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0030","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0035","first-page":"1232","article-title":"Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis)","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0040","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","article-title":"Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0045","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.20166","article-title":"Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C","volume":"39","author":"Poujol\u2010Robert","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0050","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.52.3.404","article-title":"Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis","volume":"52","author":"Papatheodoridis","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0021-9258(18)33235-6","article-title":"Protein C inhibitor. Purification from human plasma and characterization","volume":"258","author":"Suzuki","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0060","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1021\/bi00431a055","article-title":"Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and role of activated protein C in regulating this interaction: analysis by analytical ultracentrifugation","volume":"28","author":"Luckow","year":"1989","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood.V89.2.397","article-title":"A single genetic origin for a common Caucasian risk factor for venous thrombosis","volume":"89","author":"Zivelin","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2008-1040457","article-title":"Experimental models of hepatic fibrosis: a review","volume":"10","author":"Tsukamoto","year":"1990","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0075","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1182\/blood.V96.13.4222","article-title":"Spontaneous thrombosis in mice carrying the factor V Leiden mutation","volume":"96","author":"Cui","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0080","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0163-7258(89)90050-8","article-title":"Mechanisms of carbon tetrachloride toxicity","volume":"43","author":"Recknagel","year":"1989","journal-title":"Pharmacol Ther"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0090","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1083\/jcb.103.6.2787","article-title":"A monoclonal antibody against alpha\u2010smooth muscle actin: a new probe for smooth muscle differentiation","volume":"103","author":"Skalli","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0095","series-title":"User Bulletin #2 ABI PRISM 7700 Sequence Detection System","year":"1997"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0100","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2337\/diabetes.53.6.1577","article-title":"A new mouse model of type 2 diabetes, produced by N\u2010ethyl\u2010nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene","volume":"53","author":"Toye","year":"2004","journal-title":"Diabetes"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1440-1746.2005.03901.x","article-title":"Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: emphasis on sampling variability","volume":"20","author":"Lee","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1039\/an9699400575","article-title":"Lung tissue hydrolysates: studies of the optimum conditions for the spectrophotometric determination of hydroxyproline","volume":"94","author":"Bergman","year":"1969","journal-title":"Analyst"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","article-title":"Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model","volume":"33","author":"Weber","year":"2003","journal-title":"Crit Rev Toxicol"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10715769809065821","article-title":"Measurement of lipid peroxidation","volume":"28","author":"Moore","year":"1998","journal-title":"Free Radic Res"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0037-1615623","article-title":"Pulmonary fibrosis is increased in mice carrying the factor V Leiden mutation following bleomycin injury","volume":"85","author":"Xu","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0002-9440(10)62046-9","article-title":"Fibrin\u2010induced skin fibrosis in mice deficient in tissue plasminogen activator","volume":"167","author":"De Giorgio\u2010Miller","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2004.00827.x","article-title":"Pleiotropic functions of plasminogen activator inhibitor\u20101","volume":"3","author":"Lijnen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.phrs.2004.04.009","article-title":"A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat","volume":"51","author":"Abdel\u2010Salam","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0145","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/hep.510240417","article-title":"Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole","volume":"24","author":"Wanless","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0150","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0002-9440(10)62354-1","article-title":"Absence of proteinase\u2010activated receptor\u20101 signaling affords protection from bleomycin\u2010induced lung inflammation and fibrosis","volume":"166","author":"Howell","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0155","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.2201082","article-title":"Prevention of bleomycin\u2010induced lung fibrosis by aerosolization of heparin or urokinase in rabbits","volume":"168","author":"Gunther","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0160","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1378\/chest.128.3.1475","article-title":"Anticoagulant therapy for idiopathic pulmonary fibrosis","volume":"128","author":"Kubo","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0165","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0170","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c","volume":"34","author":"Poynard","year":"2001","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0175","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gut.2004.053728","article-title":"Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells","volume":"54","author":"Itagaki","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-0676.2003.00811.x","article-title":"Impact of oestrogens on the progression of liver disease","volume":"23","author":"Shimizu","year":"2003","journal-title":"Liver Int"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1021510723157","article-title":"Protease activated receptor\u20101 is down regulated by levonorgestrel in endometrial stromal cells","volume":"5","author":"Hague","year":"2002","journal-title":"Angiogenesis"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2893.2006.00790.x","article-title":"The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source","volume":"14","author":"Goulding","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0195","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMoa032959","article-title":"The risk of recurrent venous thromboembolism in men and women","volume":"350","author":"Kyrle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0200","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/hep.510270221","article-title":"Expression of the thrombin receptor in human liver: up\u2010regulation during acute and chronic injury","volume":"27","author":"Marra","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0205","first-page":"780","article-title":"Thrombin stimulates proliferation of liver fat\u2010storing cells and expression of monocyte chemotactic protein\u20101: potential role in liver injury","volume":"22","author":"Marra","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","article-title":"PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation","volume":"39","author":"Fiorucci","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2008.03015.x_bb0215","article-title":"Effect of a thrombin receptor (protease\u2010activated receptor 1, PAR\u20101) gene polymorphism in chronic hepatitis C liver fibrosis","author":"Martinelli","year":"2007","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2008.03015.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622120155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622120155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2008.03015.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:45:20Z","timestamp":1761533120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622120155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1538783622120155"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03015.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03015.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}